Achilles Therapeutics plc ACHL

Set alert

Price alert · ACHL

All alert types
1.48 0.00 0.00%

At close · Mar 20

1.48 Day range 1.48

52-week range unavailable

YTD
+29.82%
1 year
+14.73%
Open
1.48
Prev close
1.48
Mkt cap
48.70M
Vol
1.20M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.48
High
1.48
Forward P/E
-0.61
Beta
1.34
Short ratio
1.69
Inst. own
59.30%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
1.02
200-d avg
0.91881
1y target
0.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for ACHL has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 0.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 3
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ACHL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.00-0.460.0%00.0%0
Next quarter0.000.00 – 0.00-0.300.0%00.0%0
Current year0.000.00 – 0.00-1.740.0%00.0%0
Next year0.000.00 – 0.000.000.0%00.0%0

Upgrades and downgrades

The latest rating changes

ACHL analyst upgrades and downgrades
DateFirmActionFromTo
Apr 5, 2024Chardan CapitalMaintainedBuyBuy
Apr 5, 2024Piper SandlerDowngradeOverweightNeutral
Dec 14, 2023B of A SecuritiesDowngradeBuyUnderperform
Aug 7, 2023Chardan CapitalReiteratedBuyBuy
May 11, 2023Chardan CapitalMaintainedBuyBuy
Dec 7, 2022Chardan CapitalMaintained—Buy
Dec 7, 2022Piper SandlerMaintained—Overweight
Apr 26, 2021JP MorganInitiated—Underweight
Apr 26, 2021B of A SecuritiesInitiated—Buy
Apr 26, 2021Chardan CapitalInitiated—Buy
Apr 26, 2021Piper SandlerInitiated—Overweight
Apr 26, 2021OppenheimerInitiated—Outperform